Malik Moledina, Vickie Lee, Ahmed Alnahrawy, Ourania Fydanaki, Nicole George, Nour Hubby, Daisy Metcalf, Natalie Man, Gabriella Guevara, Claire Feeney, Rashmi Akshikar, Rajni Jain, Ahmad Aziz, Vassiliki Bravis, Karim Meeran
{"title":"多民族TED人群甲状腺功能障碍视神经病变发展的预测人口学和临床特征:一项回顾性队列研究。","authors":"Malik Moledina, Vickie Lee, Ahmed Alnahrawy, Ourania Fydanaki, Nicole George, Nour Hubby, Daisy Metcalf, Natalie Man, Gabriella Guevara, Claire Feeney, Rashmi Akshikar, Rajni Jain, Ahmad Aziz, Vassiliki Bravis, Karim Meeran","doi":"10.1186/s13044-025-00249-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Dysthyroid Optic Neuropathy (DON) is a sight-threatening complication of Thyroid Eye Disease (TED). This study aims to identify the risk and predictive factors for DON in a multi-ethnic TED cohort.</p><p><strong>Methods: </strong>Retrospective, cohort study of consecutive TED patients attending a multidisciplinary service over an 11-year period. Consecutive patients aged over 18 years old with a minimum of 6 months follow-up post-diagnosis of TED were included. We compared those patients with DON and those without (no-DON) to determine which factors were more prevalent in patients with DON.</p><p><strong>Results: </strong>There were 26 and 516 consecutive patients with DON and no-DON. The DON prevalence in the cohort was 5.0%. The DON group had a Mean Age at TED Diagnosis (MATD) of 57.8 vs. 46.1 years in the no-DON group. The mean presenting CAS, TRAb and Gorman Diplopia Score (GDS) were significantly higher 3.73 ± 1.80, 2.76 ± 1.05 and 11.31 ± 11.90 vs. 0.54 ± 0.80, 0.48 ± 0.90 and 6.95 ± 9.22 in the DON compared to the no-DON group respectively (p = 0.00, p = 0.00 and p = 0.04). On multivariable regression, we found the following risk factors for developing DON (Odds Ratios): MATD ≥ 53 years (5.2 p = 0.00), presenting CAS ≥ 4 (P = 0.00), presenting GDS ≥ 3 (7.5 p = 0.00), diabetes (5.7 p = 0.00), and baseline TRAb ≥ 5.0 IU/L (2.9 p = 0.04).</p><p><strong>Conclusion: </strong>Patients with diabetes, increased MATD, and high presenting CAS, GDS, and TRAb are at increased risk of developing DON in our cohort. Clinicians should be especially vigilant of the risk of sight-threatening complications in TED patients with more than one of the above risk factors.</p>","PeriodicalId":39048,"journal":{"name":"Thyroid Research","volume":"18 1","pages":"37"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281705/pdf/","citationCount":"0","resultStr":"{\"title\":\"Predictive demographic and clinical features for the development of dysthyroid optic neuropathy in a multi-ethnic TED population: a retrospective cohort study.\",\"authors\":\"Malik Moledina, Vickie Lee, Ahmed Alnahrawy, Ourania Fydanaki, Nicole George, Nour Hubby, Daisy Metcalf, Natalie Man, Gabriella Guevara, Claire Feeney, Rashmi Akshikar, Rajni Jain, Ahmad Aziz, Vassiliki Bravis, Karim Meeran\",\"doi\":\"10.1186/s13044-025-00249-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Dysthyroid Optic Neuropathy (DON) is a sight-threatening complication of Thyroid Eye Disease (TED). This study aims to identify the risk and predictive factors for DON in a multi-ethnic TED cohort.</p><p><strong>Methods: </strong>Retrospective, cohort study of consecutive TED patients attending a multidisciplinary service over an 11-year period. Consecutive patients aged over 18 years old with a minimum of 6 months follow-up post-diagnosis of TED were included. We compared those patients with DON and those without (no-DON) to determine which factors were more prevalent in patients with DON.</p><p><strong>Results: </strong>There were 26 and 516 consecutive patients with DON and no-DON. The DON prevalence in the cohort was 5.0%. The DON group had a Mean Age at TED Diagnosis (MATD) of 57.8 vs. 46.1 years in the no-DON group. The mean presenting CAS, TRAb and Gorman Diplopia Score (GDS) were significantly higher 3.73 ± 1.80, 2.76 ± 1.05 and 11.31 ± 11.90 vs. 0.54 ± 0.80, 0.48 ± 0.90 and 6.95 ± 9.22 in the DON compared to the no-DON group respectively (p = 0.00, p = 0.00 and p = 0.04). On multivariable regression, we found the following risk factors for developing DON (Odds Ratios): MATD ≥ 53 years (5.2 p = 0.00), presenting CAS ≥ 4 (P = 0.00), presenting GDS ≥ 3 (7.5 p = 0.00), diabetes (5.7 p = 0.00), and baseline TRAb ≥ 5.0 IU/L (2.9 p = 0.04).</p><p><strong>Conclusion: </strong>Patients with diabetes, increased MATD, and high presenting CAS, GDS, and TRAb are at increased risk of developing DON in our cohort. Clinicians should be especially vigilant of the risk of sight-threatening complications in TED patients with more than one of the above risk factors.</p>\",\"PeriodicalId\":39048,\"journal\":{\"name\":\"Thyroid Research\",\"volume\":\"18 1\",\"pages\":\"37\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281705/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thyroid Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s13044-025-00249-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13044-025-00249-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:甲状腺功能障碍视神经病变(DON)是甲状腺眼病(TED)的一种危及视力的并发症。本研究旨在确定多种族TED队列中DON的风险和预测因素。方法:回顾性、队列研究连续接受多学科服务的TED患者超过11年。纳入年龄在18岁以上的连续患者,在诊断为TED后至少随访6个月。我们比较了DON患者和没有DON患者(无DON),以确定哪些因素在DON患者中更普遍。结果:分别有26例DON和516例无DON患者。该队列的DON患病率为5.0%。DON组在TED诊断时的平均年龄(MATD)为57.8岁,而非DON组为46.1岁。DON组的CAS、TRAb、Gorman复视评分(GDS)均值分别为(3.73±1.80、2.76±1.05、11.31±11.90、0.54±0.80、0.48±0.90、6.95±9.22,显著高于无DON组(p = 0.00、p = 0.00、p = 0.04)。在多变量回归中,我们发现以下发生DON的危险因素(优势比):MATD≥53年(5.2 p = 0.00), CAS≥4 (p = 0.00), GDS≥3 (7.5 p = 0.00),糖尿病(5.7 p = 0.00),基线TRAb≥5.0 IU/L (2.9 p = 0.04)。结论:在我们的队列中,糖尿病患者、升高的MATD、高表现的CAS、GDS和TRAb发生DON的风险增加。临床医生应特别警惕有以上一种危险因素的TED患者出现威胁视力的并发症的风险。
Predictive demographic and clinical features for the development of dysthyroid optic neuropathy in a multi-ethnic TED population: a retrospective cohort study.
Background: Dysthyroid Optic Neuropathy (DON) is a sight-threatening complication of Thyroid Eye Disease (TED). This study aims to identify the risk and predictive factors for DON in a multi-ethnic TED cohort.
Methods: Retrospective, cohort study of consecutive TED patients attending a multidisciplinary service over an 11-year period. Consecutive patients aged over 18 years old with a minimum of 6 months follow-up post-diagnosis of TED were included. We compared those patients with DON and those without (no-DON) to determine which factors were more prevalent in patients with DON.
Results: There were 26 and 516 consecutive patients with DON and no-DON. The DON prevalence in the cohort was 5.0%. The DON group had a Mean Age at TED Diagnosis (MATD) of 57.8 vs. 46.1 years in the no-DON group. The mean presenting CAS, TRAb and Gorman Diplopia Score (GDS) were significantly higher 3.73 ± 1.80, 2.76 ± 1.05 and 11.31 ± 11.90 vs. 0.54 ± 0.80, 0.48 ± 0.90 and 6.95 ± 9.22 in the DON compared to the no-DON group respectively (p = 0.00, p = 0.00 and p = 0.04). On multivariable regression, we found the following risk factors for developing DON (Odds Ratios): MATD ≥ 53 years (5.2 p = 0.00), presenting CAS ≥ 4 (P = 0.00), presenting GDS ≥ 3 (7.5 p = 0.00), diabetes (5.7 p = 0.00), and baseline TRAb ≥ 5.0 IU/L (2.9 p = 0.04).
Conclusion: Patients with diabetes, increased MATD, and high presenting CAS, GDS, and TRAb are at increased risk of developing DON in our cohort. Clinicians should be especially vigilant of the risk of sight-threatening complications in TED patients with more than one of the above risk factors.